Stay updated on Lenvatinib and Pembrolizumab in DTC Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib and Pembrolizumab in DTC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added Hurthle cell carcinoma of thyroid and differentiated thyroid carcinoma to the conditions, and included a Resources section with the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T14:52:31.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No user-facing content or functionality is affected.
    Difference
    0.0%
    Check dated 2026-03-18T21:56:12.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a metadata version change and does not modify core content such as study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-03-11T18:55:19.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Site footer updated to Revision: v3.4.2; the government funding-lapse notice and the older Revision: v3.4.1 label were removed.
    Difference
    0.4%
    Check dated 2026-02-11T10:30:57.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, and the page shows a new revision tag (v3.4.1) replacing the previous (v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T10:14:04.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Added UI elements for glossary visibility and new metadata labels (Last Update Submitted that Met QC Criteria, Last Update Posted, Revision: v3.4.0). Removed older metadata labels (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T04:48:11.000Z thumbnail image

Stay in the know with updates to Lenvatinib and Pembrolizumab in DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib and Pembrolizumab in DTC Clinical Trial page.